Rexlemestrocel-L + HA mixture
Sponsors
Mesoblast, Ltd.
Conditions
Degenerative Disc Disease
Phase 3
Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain
CompletedNCT02412735
Start: 2015-03-06End: 2021-06-15Updated: 2022-10-19
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Active, not recruitingNCT06325566
Start: 2024-07-03End: 2028-07-01Target: 300Updated: 2026-06-17